| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 422,950 | 434,845 | 422,630 | 426,455 | | Cost of Revenue | 229,163 | 233,567 | 235,982 | 237,614 | | | Gross Profit | 193,787 | 201,278 | 186,648 | 188,841 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 106,627 | 109,044 | 153,993 | 63,313 | | Non Recurring | (11,091) | 22,380 | 237,964 | 9,193 | | Others | 42,093 | 42,652 | 41,679 | 41,573 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 56,158 | 27,202 | (246,988) | 74,762 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,553 | (2,118) | 23,005 | (32,494) | | Earnings Before Interest And Taxes | 57,711 | 25,084 | (223,983) | 42,268 | | Interest Expense | 36,235 | 45,271 | 25,323 | 27,400 | | Income Before Tax | 21,476 | (20,187) | (249,306) | 14,868 | | Income Tax Expense | 8,698 | (6,359) | (28,532) | 6,170 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 12,778 | (13,828) | (220,774) | 8,698 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 12,778 | (13,828) | (220,774) | 8,698 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $12,778 | ($13,828) | ($220,774) | $8,698 |
|
1.48% Nasdaq 
Income Statement
